| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0925-4927(97)00047-4 |
| P698 | PubMed publication ID | 9522404 |
| P2093 | author name string | Hübner G | |
| Kaiser WA | |||
| Sauer H | |||
| Volz HP | |||
| Rzanny R | |||
| Kreitschmann-Andermahr I | |||
| Rössger G | |||
| P2860 | cites work | Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy | Q43917305 |
| Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates | Q48174303 | ||
| Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients | Q48306182 | ||
| 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics--a study including 50 patients and 36 controls | Q48374121 | ||
| Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls | Q48712843 | ||
| 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique--preliminary findings | Q48764852 | ||
| P-31 MR spectroscopy of normal human brain and brain tumors | Q49117410 | ||
| Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia | Q69741294 | ||
| Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia | Q70853432 | ||
| Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration | Q33622735 | ||
| Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London | Q34245156 | ||
| ATP and brain function | Q38597443 | ||
| Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia | Q41346765 | ||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 123-129 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | Psychiatry Research | Q15750888 |
| P1476 | title | Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study | |
| P478 | volume | 76 |
| Q48374121 | 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics--a study including 50 patients and 36 controls |
| Q51734320 | Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies. |
| Q44649449 | Creatine kinase BB in brain in schizophrenia. |
| Q24631151 | Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value? |
| Q44010207 | Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groups |
| Q40078303 | Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro |
| Q39945932 | Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro |
| Q48444380 | High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation |
| Q39940395 | In vitro effect of antipsychotics on brain energy metabolism parameters in the brain of rats. |
| Q46010049 | In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. |
| Q48208705 | Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic study |
| Q34026108 | Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II. |
| Q41927221 | Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes |
| Q33186072 | Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy |
| Q90535509 | Proteostasis and Mitochondrial Role on Psychiatric and Neurodegenerative Disorders: Current Perspectives |
| Q48324144 | Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder |
| Q73851100 | Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study |
Search more.